AdvanCell
Develops lead-212 targeted alpha therapies to treat cancer
$315MSeries D
Role not disclosedPH
Piper Heartland
Activity from announced rounds
Activity in this selectionstout-street-capital-0ab0c4ce
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $315M 1 disclosed · full round size, not this investor’s share